JOANN PAOLETTI: Open Payments
NPI 1164969226 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,911 in 104 payments from 12 companies in 2025. Trend: 2023 $1,659 · 2024 $2,149 · 2025 $1,911
Food & beverage: $1,881Education: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $468 |
| Vanda Pharmaceuticals Inc. | 25 | $315 |
| Alkermes, Inc. | 15 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $273 |
| Otsuka America Pharmaceutical, Inc. | 8 | $247 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| Lundbeck LLC | 4 | $80 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Biogen, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
Products named: VRAYLAR, REXULTI, FANAPT, CAPLYTA, ARISTADA, COBENFY, LYBALVI, Qelbree.
Industry payments across NY — which companies pay providers there.
